ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr | ₹814 Cr | ₹832 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
Year | Revenue |
---|---|
Mar2024 | ₹1,296 Cr |
Mar2023 | ₹1,003 Cr |
Mar2022 | ₹806 Cr |
Mar2021 | ₹814 Cr |
Mar2020 | ₹832 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,296 Cr | 29.17 | |
Mar2023 | ₹1,003 Cr | 24.50 | |
Mar2022 | ₹806 Cr | -0.98 | |
Mar2021 | ₹814 Cr | -2.19 | |
Mar2020 | ₹832 Cr | - |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,418.5 Cr | 2.5% | 7.7% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | 2.5% |
7.7% |
7.5% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses